Eosinophilic esophagitis: Is it also a surgical disease?

Francesca Rea, Tamara Caldaro, Renato Tambucci, Erminia F. Romeo, Claudia Caloisi, Filippo Torroni, Giovanni Federici Di Abriola, Francesca Foschia, Paola Francalanci, Luigi Dall'Oglio, Paola De Angelis

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background Eosinophilic esophagitis (EoE) is a chronic immune/antigen- mediated disease with esophageal dysfunction and eosinophil-predominant inflammation. An association between EoE and gastro-esophageal reflux disease (GERD) has not been well established. Aims The aim was to evaluate patients with EoE who underwent pH-Multichannel Intraluminal Impedance (pH-MII), investigating proton-pump-inhibitors (PPI) therapy/anti-reflux surgery requirement. Methods Twenty-five patients [mean age 7.6 (range 1-17 years)] with EoE underwent pH-MII. The children were then divided into Group 1 (pathological pH-MII) and Group 2 (normal pH-MII). PPI was administered for two months in Group 1 and in those children in Group 2 unresponsive to standard EoE therapy (diet and corticosteroids). All patients underwent endoscopy and clinical follow-up. Data are described as mean (range). Results Group 1 (n = 16, M:F = 14:2) had mean reflux index (RI) 13.9% (0.8%-53.4%) with a mean number of total reflux episodes (RE) of 65.8 (14-341). Group 2 (n = 9, M:F = 6:3) had a mean RI 1.2% (0.2%-2.7%) with a mean number of total RE of 27.4 (14-39). There was a histological response to repeated cycles of PPI in 11/16 (69%) children in Group 1 and 4/9 (44%) children in Group 2. Fundoplication, because of dependence on PPI, was required in 4/11 PPI-responders in Group 1, allowing discontinuation without relapse of EoE. Conclusions The use of PPI is suggested in EoE at time of diagnosis in addition to standard treatment and may even have benefit in children who do not appear to have significant GERD but are unresponsive to standard therapy.

Original languageEnglish
Pages (from-to)304-308
Number of pages5
JournalJournal of Pediatric Surgery
Volume48
Issue number2
DOIs
Publication statusPublished - Feb 2013

Fingerprint

Eosinophilic Esophagitis
Proton Pump Inhibitors
Esophageal Diseases
Electric Impedance
Gastroesophageal Reflux
Diet Therapy
Fundoplication
Eosinophils
Endoscopy
Adrenal Cortex Hormones
Therapeutics
Inflammation
Antigens
Recurrence

Keywords

  • Antireflux surgery
  • Eosinophilic esophagitis
  • Gastro Esophageal Reflux Disease (GERD)
  • Proton pump Inhibitors

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Cite this

Eosinophilic esophagitis : Is it also a surgical disease? / Rea, Francesca; Caldaro, Tamara; Tambucci, Renato; Romeo, Erminia F.; Caloisi, Claudia; Torroni, Filippo; Di Abriola, Giovanni Federici; Foschia, Francesca; Francalanci, Paola; Dall'Oglio, Luigi; De Angelis, Paola.

In: Journal of Pediatric Surgery, Vol. 48, No. 2, 02.2013, p. 304-308.

Research output: Contribution to journalArticle

Rea, Francesca ; Caldaro, Tamara ; Tambucci, Renato ; Romeo, Erminia F. ; Caloisi, Claudia ; Torroni, Filippo ; Di Abriola, Giovanni Federici ; Foschia, Francesca ; Francalanci, Paola ; Dall'Oglio, Luigi ; De Angelis, Paola. / Eosinophilic esophagitis : Is it also a surgical disease?. In: Journal of Pediatric Surgery. 2013 ; Vol. 48, No. 2. pp. 304-308.
@article{aeb1fecd399649f3addd8d8b413c0fa6,
title = "Eosinophilic esophagitis: Is it also a surgical disease?",
abstract = "Background Eosinophilic esophagitis (EoE) is a chronic immune/antigen- mediated disease with esophageal dysfunction and eosinophil-predominant inflammation. An association between EoE and gastro-esophageal reflux disease (GERD) has not been well established. Aims The aim was to evaluate patients with EoE who underwent pH-Multichannel Intraluminal Impedance (pH-MII), investigating proton-pump-inhibitors (PPI) therapy/anti-reflux surgery requirement. Methods Twenty-five patients [mean age 7.6 (range 1-17 years)] with EoE underwent pH-MII. The children were then divided into Group 1 (pathological pH-MII) and Group 2 (normal pH-MII). PPI was administered for two months in Group 1 and in those children in Group 2 unresponsive to standard EoE therapy (diet and corticosteroids). All patients underwent endoscopy and clinical follow-up. Data are described as mean (range). Results Group 1 (n = 16, M:F = 14:2) had mean reflux index (RI) 13.9{\%} (0.8{\%}-53.4{\%}) with a mean number of total reflux episodes (RE) of 65.8 (14-341). Group 2 (n = 9, M:F = 6:3) had a mean RI 1.2{\%} (0.2{\%}-2.7{\%}) with a mean number of total RE of 27.4 (14-39). There was a histological response to repeated cycles of PPI in 11/16 (69{\%}) children in Group 1 and 4/9 (44{\%}) children in Group 2. Fundoplication, because of dependence on PPI, was required in 4/11 PPI-responders in Group 1, allowing discontinuation without relapse of EoE. Conclusions The use of PPI is suggested in EoE at time of diagnosis in addition to standard treatment and may even have benefit in children who do not appear to have significant GERD but are unresponsive to standard therapy.",
keywords = "Antireflux surgery, Eosinophilic esophagitis, Gastro Esophageal Reflux Disease (GERD), Proton pump Inhibitors",
author = "Francesca Rea and Tamara Caldaro and Renato Tambucci and Romeo, {Erminia F.} and Claudia Caloisi and Filippo Torroni and {Di Abriola}, {Giovanni Federici} and Francesca Foschia and Paola Francalanci and Luigi Dall'Oglio and {De Angelis}, Paola",
year = "2013",
month = "2",
doi = "10.1016/j.jpedsurg.2012.11.006",
language = "English",
volume = "48",
pages = "304--308",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Eosinophilic esophagitis

T2 - Is it also a surgical disease?

AU - Rea, Francesca

AU - Caldaro, Tamara

AU - Tambucci, Renato

AU - Romeo, Erminia F.

AU - Caloisi, Claudia

AU - Torroni, Filippo

AU - Di Abriola, Giovanni Federici

AU - Foschia, Francesca

AU - Francalanci, Paola

AU - Dall'Oglio, Luigi

AU - De Angelis, Paola

PY - 2013/2

Y1 - 2013/2

N2 - Background Eosinophilic esophagitis (EoE) is a chronic immune/antigen- mediated disease with esophageal dysfunction and eosinophil-predominant inflammation. An association between EoE and gastro-esophageal reflux disease (GERD) has not been well established. Aims The aim was to evaluate patients with EoE who underwent pH-Multichannel Intraluminal Impedance (pH-MII), investigating proton-pump-inhibitors (PPI) therapy/anti-reflux surgery requirement. Methods Twenty-five patients [mean age 7.6 (range 1-17 years)] with EoE underwent pH-MII. The children were then divided into Group 1 (pathological pH-MII) and Group 2 (normal pH-MII). PPI was administered for two months in Group 1 and in those children in Group 2 unresponsive to standard EoE therapy (diet and corticosteroids). All patients underwent endoscopy and clinical follow-up. Data are described as mean (range). Results Group 1 (n = 16, M:F = 14:2) had mean reflux index (RI) 13.9% (0.8%-53.4%) with a mean number of total reflux episodes (RE) of 65.8 (14-341). Group 2 (n = 9, M:F = 6:3) had a mean RI 1.2% (0.2%-2.7%) with a mean number of total RE of 27.4 (14-39). There was a histological response to repeated cycles of PPI in 11/16 (69%) children in Group 1 and 4/9 (44%) children in Group 2. Fundoplication, because of dependence on PPI, was required in 4/11 PPI-responders in Group 1, allowing discontinuation without relapse of EoE. Conclusions The use of PPI is suggested in EoE at time of diagnosis in addition to standard treatment and may even have benefit in children who do not appear to have significant GERD but are unresponsive to standard therapy.

AB - Background Eosinophilic esophagitis (EoE) is a chronic immune/antigen- mediated disease with esophageal dysfunction and eosinophil-predominant inflammation. An association between EoE and gastro-esophageal reflux disease (GERD) has not been well established. Aims The aim was to evaluate patients with EoE who underwent pH-Multichannel Intraluminal Impedance (pH-MII), investigating proton-pump-inhibitors (PPI) therapy/anti-reflux surgery requirement. Methods Twenty-five patients [mean age 7.6 (range 1-17 years)] with EoE underwent pH-MII. The children were then divided into Group 1 (pathological pH-MII) and Group 2 (normal pH-MII). PPI was administered for two months in Group 1 and in those children in Group 2 unresponsive to standard EoE therapy (diet and corticosteroids). All patients underwent endoscopy and clinical follow-up. Data are described as mean (range). Results Group 1 (n = 16, M:F = 14:2) had mean reflux index (RI) 13.9% (0.8%-53.4%) with a mean number of total reflux episodes (RE) of 65.8 (14-341). Group 2 (n = 9, M:F = 6:3) had a mean RI 1.2% (0.2%-2.7%) with a mean number of total RE of 27.4 (14-39). There was a histological response to repeated cycles of PPI in 11/16 (69%) children in Group 1 and 4/9 (44%) children in Group 2. Fundoplication, because of dependence on PPI, was required in 4/11 PPI-responders in Group 1, allowing discontinuation without relapse of EoE. Conclusions The use of PPI is suggested in EoE at time of diagnosis in addition to standard treatment and may even have benefit in children who do not appear to have significant GERD but are unresponsive to standard therapy.

KW - Antireflux surgery

KW - Eosinophilic esophagitis

KW - Gastro Esophageal Reflux Disease (GERD)

KW - Proton pump Inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84873657302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873657302&partnerID=8YFLogxK

U2 - 10.1016/j.jpedsurg.2012.11.006

DO - 10.1016/j.jpedsurg.2012.11.006

M3 - Article

C2 - 23414856

AN - SCOPUS:84873657302

VL - 48

SP - 304

EP - 308

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 2

ER -